Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biological Dating of Cerebral Ischemia With GST-π/PRDX1 to Detect Patients With Stroke of Unknown Onset Within the Therapeutic Window of Thrombolysis
Sponsor: Central Hospital, Nancy, France
Summary
The FLAG1 study will assess the diagnostic performance of biomarkers Glutathion S-Transferase-π (GST-π) and Peroxyredoxin 1 (PRDX1) to identify cerebral infarction of less than 4,5 hours in a population of patients with neurological deficiency of less than 12 hours.
Official title: Biological Dating of Cerebral Ischemia With Glutathion S-Transferase-π (GST-π) and Peroxyredoxin 1 (PRDX1) to Detect Patients With Stroke of Unknown Onset Within the Therapeutic Window of Thrombolysis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
930
Start Date
2018-10-15
Completion Date
2025-03-01
Last Updated
2024-05-17
Healthy Volunteers
No
Conditions
Interventions
Blood Samples
Blood sample retrieved for biological assessment and biobanking
Locations (5)
Centre Hospitalier de Bar-Le-Duc
Bar-le-Duc, France
Hôpital Central
Nancy, France
Fondation Adolphe de Rothschild
Paris, France
Centre Hospitalier de Troyes
Troyes, France
Centre Hospitalier de Verdun
Verdun, France